0001437749-23-032239.txt : 20231115 0001437749-23-032239.hdr.sgml : 20231115 20231115215518 ACCESSION NUMBER: 0001437749-23-032239 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231113 FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Demopulos Gregory A MD CENTRAL INDEX KEY: 0001472160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34475 FILM NUMBER: 231412294 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OMEROS CORP CENTRAL INDEX KEY: 0001285819 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911663741 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 206-676-5000 MAIL ADDRESS: STREET 1: 201 ELLIOTT AVENUE WEST CITY: SEATTLE STATE: WA ZIP: 98119 4 1 rdgdoc.xml FORM 4 X0508 4 2023-11-13 0001285819 OMEROS CORP OMER 0001472160 Demopulos Gregory A MD 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 1 Chairman, CEO & President 0 Common Stock 2023-11-13 4 A 0 37500 1.29 A 83945 I By Spouse Common Stock 2023-11-14 4 A 0 25000 1.44 A 108945 I By Spouse Common Stock 2026986 D This transaction was executed in multiple trades at prices ranging from $1.26 to $1.30. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose. The shares reported herein include shares held by the reporting person's spouse with respect to which it was previously determined that the reporting person did not have an indirect pecuniary interest. This transaction was executed in multiple trades at prices ranging from $1.43 to $1.45. The price reported above reflects the weighted average sales price.The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in thisfootnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose. /s/ Peter Cancelmo, Attorney-in-Fact 2023-11-15